Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Systematic discovery of multicomponent therapeutics

Open access
Borisy, Alexis A., Elliott, Peter J., Hurst, Nicole W., Lee, Margaret S., Lehár, Joseph, Price, E. Roydon, Serbedzija, George, Zimmermann, Grant R., Foley, Michael A., Stockwell, Brent R., Keith, Curtis T. · 2003 · Proceedings of the National Academy of Sciences

Abstract

Multicomponent therapies, originating through deliberate mixing of drugs in a clinical setting, through happenstance, and through rational design, have a successful history in a number of areas of medicine, including cancer, infectious diseases, and CNS disorders. We have developed a high-throughput screening method for identifying effective combinations of therapeutic compounds. We report here that systematic screening of combinations of small molecules reveals unexpected interactions between compounds, presumably due to interactions between the pathways on which they act. Through systematic screening of ≈120,000 different two-component combinations of reference-listed drugs, we identified potential multicomponent therapeutics, including ( i ) fungistatic and analgesic agents that together generate fungicidal activity in drug-resistant Candida albicans , yet do not significantly affect human cells, ( ii ) glucocorticoid and antiplatelet agents that together suppress the production of tumor necrosis factor-α in human primary peripheral blood mononu-clear cells, and ( iii ) antipsychotic and antiprotozoal agents that do not exhibit significant antitumor activity alone, yet together prevent the growth of tumors in mice. Systematic combination screening may ultimately be useful for exploring the connectivity of biological pathways and, when performed with reference-listed drugs, may result in the discovery of new combination drug regimens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1337088100

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Research works printed but not linked: 10

  1. Shaheen, R. M., Tseng, W. W., Davis, D. W., Liu, W., Reinmuth, N., Vellagas, R., Wieczorek, A. A., Ogura, Y., McConkey, D. J., Drazan, K. E., et al. (2001) Cancer Res. 61, 1464-1468.11245452
  2. Berenbaum, M. C. (1989) Pharmacol. Rev. 2, 93-141.
  3. Loewe, S. (1953) Arzneim.-Forsch. 3, 285-290.13081480
  4. DeVita V. T. Jr. (1997) in Principles of Cancer Management: Chemotherapy eds. DeVita V. T. Jr. Hellman S. & Rosenberg S. A. (Lippincott Philadelphia) pp. 333-347.
  5. Di Leo, A. & Piccart, M. J. (1999) Semin. Oncol. 26, 27-32.
  6. Fraser, T. R. (1871) Proc. Roy. Soc. Edinburgh 7, 506-511.
  7. Konstantinov, K., Galabov, A. & Mastikova, M. (1989) Br. J. Dermatol. 121, 59-63.2757956
  8. Hardman J. G. & Limbird L. E. (2001) Goodman and Gilman's The Pharmacological Basis of Therapeutics (McGraw–Hill New York) 10th Ed.
  9. Lazo, J. S., Chen, D. L., Gallicchio, V. S. & Hait, W. N. (1986) Cancer Res. 46, 2236-2240.2421873
  10. Lowe, P. R., Sansom, C. E., Schwalbe, C. H. & Stevens, M. F. G. (1989) J. Chem. Soc. Chem. Commun. 16, 1164-1165.

Cited by

See all 666

Metadata

Authors
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., & Keith, C. T.
Affiliations
CombinatoRx Incorporated, 650 Albany Street, Boston, MA 02118
Venue
Proceedings of the National Academy of Sciences
Published
2003-06-10
Volume
100
Issue
13
Pages
7977-7982
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2115147179
Cited by
620
References
44
Citations by year
2026: 11 · 2025: 13 · 2024: 14 · 2023: 38 · 2022: 21 · 2021: 24 · 2020: 29 · 2019: 28 · 2018: 27 · 2017: 26 · 2016: 47 · 2015: 52 · 2014: 36 · 2013: 31 · 2012: 35
FWCI
17.60
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Columbia Academic Commons (Columbia University)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
Keywords
drug combination screening, high-throughput screening, drug interactions, pathway interactions, fungicidal activity, glucocorticoids, antiplatelet agents, TNF-α, antipsychotic drugs, antiprotozoal agents, anticancer activity, combination therapy
MeSH terms
Animals, Antifungal Agents, Automation, Candida albicans, Cell Division, Colony-Forming Units Assay, Dose-Response Relationship, Drug, Drug Resistance, Microbial, Drug Evaluation, Preclinical, Drug Screening Assays, Antitumor, Enzyme-Linked Immunosorbent Assay, Humans, Interferon-gamma, Neoplasm Transplantation, Neoplasms, RNA, Tumor Cells, Cultured, Tumor Necrosis Factor-alpha, Drug Design, Fluconazole, Cytokines, DNA, Complementary, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Systematic discovery of multicomponent therapeutics. https://app.cochat.ai/papers/10.1073/pnas.1337088100
The paper
Borisy, A. A., Elliott, P. J., Hurst, N. W., Lee, M. S., Lehár, J., Price, E. R., Serbedzija, G., Zimmermann, G. R., Foley, M. A., Stockwell, B. R., & Keith, C. T. (2003). Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1337088100

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.